Thalia Therapeutics Plc (AIM:THAT)
0.5750
-0.0500 (-8.00%)
Apr 15, 2026, 4:21 PM GMT
Thalia Therapeutics Revenue
Thalia Therapeutics had revenue of 3.69K GBP in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 7.07K, up 20.60% year-over-year. In the year 2024, Thalia Therapeutics had annual revenue of 7.28K with 272.86% growth.
Revenue (ttm)
7.07K
Revenue Growth
+20.60%
P/S Ratio
677.27
Revenue / Employee
1.77K
Employees
4
Market Cap
4.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.28K | 5.33K | 272.86% |
| Dec 31, 2023 | 1.95K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Futura Medical | 7.93M |
| IXICO | 6.53M |
| OptiBiotix Health | 1.15M |
| Oxford BioDynamics | 1.10M |
| Physiomics | 1.01M |
| BSF Enterprise | 52.84K |
| ValiRx | 49.78K |
| CRISM Therapeutics | 25.00K |